logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
P

Premal H. Thaker

New York University
H指数:47
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Long-term efficacy and safety of avutometinib plus defactinib in recurrent low-grade serous ovarian cancer: Results of a 2-year follow-up of ENGOT-OV60/GOG-3052/RAMP 201

奥拉帕尼联合达芬钦在复发性低级别浆液性卵巢癌中的长期疗效与安全性：ENGOT-OV60/GOG-3052/RAMP 201研究2年随访结果

Gynecologic Oncology
IF4.1
2026-09-010
OAAI
Grisham, Rachel N.; Van Nieuwenhuysen, Els; Santin, Alessandro D.; D'Hondt, Veronique; Thaker, Premal H.; Clamp, Andrew R.; Moore, Kathleen N.; Aghajanian, Carol; Oaknin, Ana; O'Malley, David M.; Monk, Bradley J.; Colombo, Nicoletta; Prendergast, Emily N.; Ring, Kari L.; Ray-Coquard, Isabelle; Rose, Peter G.; Gourley, Charlie; Holloway, Robert W.; Chon, Hye Sook; Van Gorp, Toon; Youssou, Hagop; Salinas, Erin; Lustgarten, Stephanie; Banerjee, Susana N.
MLH1 promoter hypermethylation and associations with survival outcomes: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

MLH1启动子高甲基化及其与生存结局的关联：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

Gynecologic Oncology
IF4.1
2026-07-010
PRE
Borden, Lindsay E.; Cosgrove, Casey M.; Washington, Christina R.; Thomas, Samantha M.; Haight, Paulina J.; Brown, Ashley; Powell, Kristina; Harsono, Adrian; Mullen, Margaret; Crafton, Sarah; Jackson, Amanda L.; Corr, Bradley R.; Wright, Jason D.; Konecny, Gottfried E.; Bae-Jump, Victoria L.; Podwika, Sarah E.; Smitherman, Carson; Maxwell, G. Larry; Backes, Floor J.; Pothuri, Bhavana; Ko, Emily M.; Arend, Rebecca C.; Thaker, Premal H.; Duska, Linda R.; Secord, Angeles Alvarez; Moore, Kathleen N.
The combination of avutometinib and defactinib in treating recurrent low-grade serous ovarian cancer: a plain language summary of the Phase II clinical trial ENGOT-OV60/GOG-3052/RAMP 201

阿伐木单抗与德法他尼联用治疗复发性低级别浆液性卵巢癌：ENGOT-OV60/GOG-3052/RAMP 201 II期临床试验的通俗语言总结

Future Oncology
IF2.6
2025-12-120
OAAI
Susana N. Banerjee; Els Van Nieuwenhuysen; Carol Aghajanian; Véronique D’Hondt; Bradley J. Monk; Andrew Clamp; Emily Prendergast; Ana Oaknin; Kari Ring; Nicoletta Colombo; Robert W. Holloway; Manuel Rodrigues; Hye Sook Chon; Charlie Gourley; Alessandro D. Santin; Premal H. Thaker; Christine Gennigens; Gregg Newman; Erin Salinas; Hagop Youssoufian; Kathleen N. Moore; Stephanie Lustgarten; David M. O’Malley; Toon Van Gorp; Rachel N. Grisham
Comparison of breast and gastric HER2 immunohistochemistry (IHC) scoring criteria in the assessment of endometrial carcinoma

乳腺癌和胃癌HER2免疫组化（IHC）评分标准在子宫内膜癌评估中的比较

Gynecologic Oncology
IF3.7
2025-11-130
OAAI
Rachel L. Furuya; Whitney Grither; Mark G. Evans; Sharon Wu; Jaclyn F. Hechtman; Harris B. Krause; Andrew Elliott; Cara Mathews; Matthew T. Oliver; Katherine Miller; Shuanzeng Wei; Rouba Ali-Fehmi; David A. Bryant; Matthew J. Oberley; Matthew A. Powell; Premal H. Thaker
Corrigendum to ‘OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer’ [Gynecol Oncol 2025 Jun 197 182–191]

勘误：‘OVATION-2：一项评估IMNN-001（IL-12基因疗法）联合新辅助化疗在 newly-diagnosed advanced epithelial ovarian cancer 患者中安全性与有效性的随机I/II期研究’ [Gynecol Oncol 2025 Jun 197 182–191]

Gynecologic Oncology
IF3.7
2025-11-060
PRE
Premal H. Thaker; Debra L. Richardson; Andrea R. Hagemann; Robert W. Holloway; Mark Reed; Melanie K. Bergman; Bhavana Pothuri; Stephen DePasquale; Jennifer M. Scalici; Amy J. Bregar; Christopher J. Darus; Karen Finkelstein; Charles A. Leath; Maria Bell; David P. Warshal; Richy Agajanian; Megan D. Indermaur; Alberto A. Mendivil; Diane M. Provencher; Lee-Jen Wei; Nicholas Borys; Lauren Musso; Stacy R. Lindborg; Douglas V. Faller; Khursheed Anwer; William H. Bradley
Prospective assessment of prognostic significance of malignant peritoneal cytology in endometrial cancer: An NRG Oncology / Gynecologic Oncology Group study on GOG-210 protocol

前瞻性评估恶性腹水细胞学在子宫内膜癌中预后意义：一项NRG Oncology/妇科肿瘤学组关于GOG-210方案的研究

gynecologic oncology
IF4.1
2025-09-030
PRE
Koji Matsuo; Danielle M. Enserro; Jason D. Wright; Lynda D. Roman; Matthew A. Powell; David S. Miller; Christa I. Nagel; Premal H. Thaker; Robert S. Mannel; Ashley R. Stuckey; Saketh R. Guntupalli; Paniti Sukumvanich; Melissa A. Geller; Roberto Vargas; Gottfried E. Konecny; David P. Warshal; Krishnansu S. Tewari; Nick M. Spirtos; Bhavana Pothuri; William T. Creasman; David G. Mutch
Impact of molecular and immune signature on endometrial biopsies with atypical hyperplasia with and without concurrent endometroid carcinoma

分子和免疫特征对伴有和不伴有同时性子宫内膜样癌的不典型增生子宫内膜活检的影响

GYNECOLOGIC ONCOLOGY REPORTS
IF0
2025-09-010
OAAI
Wong, Terrence; Fresia, Joellen; Adzibolosu, Nicholas; Corey, Logan; Wu, Sharon; Mattei, Larissa; Xiu, Joanne; Hodges, Kurt; Oberley, Matthew; Thaker, Premal H.; Musallam, Rami; Kheil, Mira; Bandyopadhyay, Sudeshna; Winer, Ira; Morris, Robert; Ali-Fehmi, Rouba
Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2)

高肿瘤突变负荷、高微卫星不稳定性及错配修复缺陷患者的种族和族裔分子特征：多机构子宫内膜癌分子靶向治疗联盟（ECMT2）的真实世界数据

gynecologic oncology
IF4.1
2025-07-110
PRE
Sarah S. Lee; Angeles Alvarez Secord; Steven Friedman; Erinn M. Hade; Carson Smitherman; Nikita Bisht; Lindsay Borden; Amanda L. Jackson; Floor Backes; Premal Thaker; Rebecca Arend; Jason D. Wright; Bradley Corr; Emily Ko; Gottfried Konecny; Sarah Podwika; Victoria Bae-Jump; Kari E. Hacker; Bhavana Pothuri
Impact of adding the immune checkpoint inhibitor atezolizumab to first-line chemotherapy on progression-free survival in poor-prognosis ovarian cancer: A retrospective analysis from the IMagyn050 trial

在预后不良的卵巢癌中，添加免疫检查点抑制剂atezolizumab到一线化疗对无进展生存期的影响：IMagyn050试验的一项回顾性分析

gynecologic oncology
IF4.1
2025-06-010
OAAI
You, Benoit; Anderson, Charles; Cecere, Sabrina Chiara; Carrot, Aurore; Myers, Tashanna; Heitz, Florian; Sharma, Sudarshan; Selcukbiricik, Fatih; Aghajanian, Carol; Fernebro, Josefin; Blank, Stephanie; Laudani, Maria Elena; Thaker, Premal H.; Yunokawa, Mayu; Willmott, Lyndsay; Lisyanskaya, Alla; Hegg, Roberto; He, Yvette; Landen, Charles; Lin, Yvonne G.; Alarcon, Jesus; Moore, Kathleen N.
Genomic alterations, molecularly targeted therapy, and survival: a real-world Endometrial Cancer Molecularly Targeted Therapy Consortium cohort study

基因组改变、分子靶向治疗与生存：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2025-05-010
PRE
Secord, Angeles Alvarez; Bae-Jump, Victoria; Backes, Floor; Thaker, Premal; Gehrig, Paola A.; Previs, Rebecca A.; Borden, Lindsay; Thomas, Samantha M.; Jackson, Amanda; Konecny, Gottfried E.; Duska, Linda R.; Arend, Rebecca; Wright, Jason; Corr, Bradley; Maxwell, G. Larry; Cosgrove, Casey M.; Mullen, Maggie M.; Washington, Christina; Herzog, Thomas J.; Cohen, Joshua; Hou, June; Gaillard, Stephanie; Fader, Amanda Nickles; Berchuck, Andrew; Pothuri, Bhavana
GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301: a phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of treatment in patients with recurrent low grade serous ovarian cancer

GOG-3097/ENGOT-ov81/GTG-UK/RAMP 301：一项评估阿伏莫替尼联合达法他尼与研究者选择治疗方案相比，在复发性低级别浆液性卵巢癌患者中的随机III期试验

International Journal of Gynecological Cancer
IF4.7
2025-04-190
OAAI
Rachel Grisham; Bradley J. Monk; Els Van Nieuwenhuysen; Kathleen Nadine Moore; Michel Fabbro; David M. O’Malley; Ana Oaknin; Premal Thaker; Amit M. Oza; Nicoletta Colombo; David Gershenson; Carol A. Aghajanian; Chel Hun Choi; Yeh Chen Lee; Mansoor Raza Mirza; Robert L. Coleman; Lauren Cobb; Philipp Harter; Stephanie Lustgarten; Hagop Youssoufian; Susana Banerjee
Platinum-free interval and response to platinum retreatment or lenvatinib/pembrolizumab in patients with recurrent endometrial cancer: A real-world endometrial cancer molecularly targeted therapy consortium cohort study

无铂间期及对复发性子宫内膜癌患者铂类再治疗或lenvatinib/pembrolizumab的应答：一项真实世界子宫内膜癌分子靶向治疗联盟队列研究

gynecologic oncology
IF4.1
2025-03-010
PRE
Haight, Paulina J.; Sanchez, Marilyn; Thomas, Samantha M.; Smitherman, Carson; Cosgrove, Casey; Bae-Jump, Victoria; Crafton, Sarah; Hacker, Kari; Ko, Emily; Krivak, Thomas; Lara, Olivia; Moore, Kathleen; Mullen, Mary M.; Pothuri, Bhavana; Thaker, Premal H.; Washington, Christina; Arend, Rebecca; Corr, Bradley; Duska, Linda; Jackson, Amanda; Konecny, Gottfried E.; Wright, Jason; Secord, Angeles; Backes, Floor
Characteristics and real-world outcomes of patients with epithelial ovarian cancer who received niraparib plus bevacizumab first-line maintenance therapy in the COMB1NE study

在COMB1NE研究中，接受尼拉帕利联合贝伐珠单抗一线维持治疗的上皮性卵巢癌患者的特征及真实世界结局。

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
IF4.7
2024-12-010
OAAI
Thaker, Premal H.; Boyle, Tirza Areli Calderon; Burns, Sara; Hartman, John; Kalilani, Linda V.; Schilder, Jeanne M.; Hurteau, Jean A.; Golembesky, Amanda K.
Ovarian Cancer/Fallopian Tube Cancer/Primary PeritonealCancer, Version 3.2024Featured Updates to the NCCN Guidelines

卵巢癌/输卵管癌/原发性腹膜癌，版本3.2024 NCCN指南重点更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK
IF16.4
2024-10-0115
PRE
Liu, Joyce; Berchuck, Andrew; Backes, Floor J.; Cohen, Joshua; Grisham, Rachel; Leath, Charles A., III; Martin, Lainie; Matei, Daniela; Miller, David S.; Robertson, Sharon; Barroilhet, Lisa; Uppal, Shitanshu; Hendrickson, Andrea Wahner; Gershenson, David M.; Gray, Heidi J.; Hakam, Ardeshir; Jain, Angela; Konecny, Gottfried E.; Moroney, John; Ratner, Elena; Schorge, John; Thaker, Premal H.; Werner, Theresa L.; Zsiros, Emese; Behbakht, Kian; Chen, Lee-May; Derosa, Marie; Eisenhauer, Eric L.; Leiserowitz, Gary; Litkouhi, Babak; Mchale, Michael; Percac-Lima, Sanja; Rodabaugh, Kerry; Vargas, Roberto; Jones, Frankie; Kovach, Emily; Hang, Lisa; Ramakrishnan, Swathi; Alvarez, Ronald D.; Armstrong, Deborah K.

研究方向

暂未获取到该数据
D
David G. Mutch
H 指数:99论文数:980被引数:4.7万
S
Susan K. Lutgendorf
H 指数:87论文数:352被引数:2.3万
A
Anil K. Sood
H 指数:174论文数:3,261被引数:18.1万
M
Matthew A. Powell
H 指数:50论文数:484被引数:1.0万
M
Michael J. Goodheart
H 指数:35论文数:232被引数:3,658
A
Andrea R. Hagemann
H 指数:29论文数:418被引数:4,074
S
Steve W. Cole
H 指数:111论文数:727被引数:4.3万
G
George M. Slavich
H 指数:63论文数:344被引数:2.1万
L
Lindsay M. Kuroki
H 指数:20论文数:335被引数:2,109
C
Carolyn K. McCourt
H 指数:26论文数:382被引数:2,964